Clinical Trial Update: The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study

View source ↗

Summary

A real-world study examining the effectiveness and safety of dupilumab for children with asthma in China; the trial is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Asthma in Children | Status: ENROLLING_BY_INVITATION